124 related articles for article (PubMed ID: 18019020)
1. Analysis of associations of NAT2 gene polymorphisms with the risk of lung cancer.
Nikishina MV; Vavilin VA; Makarova SI; Lyakhovich VV
Bull Exp Biol Med; 2007 Jan; 143(1):83-6. PubMed ID: 18019020
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.
Zhou W; Liu G; Thurston SW; Xu LL; Miller DP; Wain JC; Lynch TJ; Su L; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):15-21. PubMed ID: 11815396
[TBL] [Abstract][Full Text] [Related]
3. [Polymorphism in the N-acetyltransferase 2 gene in patients with lung cancer. Short communication].
Zabost A; Roszkowska-Śliż B; Wiatr E; Radzikowska E; Rogala E; Zych J; Zwolska Z; Augustynowicz-Kopeć E; Roszkowski-Śliż K; Szczepulska-Wójcik E
Pneumonol Alergol Pol; 2012; 80(4):323-8. PubMed ID: 22714076
[TBL] [Abstract][Full Text] [Related]
4. N-Acetyltransferase 2 (NAT2) gene polymorphism and exposure to smoking in lung cancer of Chinese males.
Tian F; Zhang Y; Ren Y; Shen L; Wu W; Zhou B
Med Oncol; 2014 Aug; 31(8):90. PubMed ID: 25005845
[TBL] [Abstract][Full Text] [Related]
5. Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility.
Liu C; Cui W; Cong L; Wang L; Ruan X; Jia J; Liu Y; Jia X; Zhang X
Medicine (Baltimore); 2015 Dec; 94(49):e1947. PubMed ID: 26656326
[TBL] [Abstract][Full Text] [Related]
6. Association of CYP2E1 and NAT2 polymorphisms with lung cancer susceptibility among Mongolian and Han populations in the Inner Mongolian region.
Zhang JW; Yu WJ; Sheng XM; Chang FH; Bai TY; Lv XL; Wang G; Liu SZ
Asian Pac J Cancer Prev; 2014; 15(21):9203-10. PubMed ID: 25422202
[TBL] [Abstract][Full Text] [Related]
7. Glutathione S-transferase mu1 and N-acetyltransferase 2 genetic polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls.
Nyberg F; Hou SM; Hemminki K; Lambert B; Pershagen G
Cancer Epidemiol Biomarkers Prev; 1998 Oct; 7(10):875-83. PubMed ID: 9796632
[TBL] [Abstract][Full Text] [Related]
8. NAT2 polymorphism and lung cancer risk: a meta-analysis.
Cui D; Wang Z; Zhao E; Ma J; Lu W
Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer.
Sørensen M; Autrup H; Tjønneland A; Overvad K; Raaschou-Nielsen O
Cancer Lett; 2005 Apr; 221(2):185-90. PubMed ID: 15808404
[TBL] [Abstract][Full Text] [Related]
10. Impact of interaction of polymorphic forms of p53 codon 72 and N-acetylation gene (NAT2) on the risk of lung cancer in the North Indian population.
Sobti RC; Kaur P; Kaur S; Janmeja AK; Jindal SK; Kishan J; Raimondi S
DNA Cell Biol; 2009 Sep; 28(9):443-9. PubMed ID: 19558213
[TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk.
Ambrosone CB; Freudenheim JL; Graham S; Marshall JR; Vena JE; Brasure JR; Michalek AM; Laughlin R; Nemoto T; Gillenwater KA; Shields PG
JAMA; 1996 Nov; 276(18):1494-501. PubMed ID: 8903261
[TBL] [Abstract][Full Text] [Related]
12. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status.
Osawa Y; Osawa KK; Miyaishi A; Higuchi M; Tsutou A; Matsumura S; Tabuchi Y; Tsubota N; Takahashi J
Asian Pac J Cancer Prev; 2007; 8(1):103-8. PubMed ID: 17477782
[TBL] [Abstract][Full Text] [Related]
13. [Restriction analysis of N-acetyltransferase 2 gene in Caucasian population of West Siberia].
Nikishina MV; Makarova SI; Akishev AG; Vavilin VA; Degtiarev SKh; Liakhovich VV
Genetika; 2004 Nov; 40(11):1557-61. PubMed ID: 15612575
[TBL] [Abstract][Full Text] [Related]
14. Modifying Effect of Smoking on GSTM1 and NAT2 in Relation to the Risk of Bladder Cancer in Mongolian Population: A Case-Control Study.
Avirmed S; Khuanbai Y; Sanjaajamts A; Selenge B; Dagvadorj BU; Ohashi M
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2479-2485. PubMed ID: 34452561
[TBL] [Abstract][Full Text] [Related]
15. 'Comparison of extremes' approach provides evidence against the modifying role of NAT2 polymorphism in lung cancer susceptibility.
Belogubova EV; Kuligina ESh; Togo AV; Karpova MB; Ulibina JM; Shutkin VA; Hanson KP; Popowski K; Mosyagin I; Cascorbi I; Hirvonen A; Imyanitov EN
Cancer Lett; 2005 Apr; 221(2):177-83. PubMed ID: 15808403
[TBL] [Abstract][Full Text] [Related]
16. Relevance of N-acetyltransferase 1 and 2 (NAT1, NAT2) genetic polymorphisms in non-small cell lung cancer susceptibility.
Wikman H; Thiel S; Jäger B; Schmezer P; Spiegelhalder B; Edler L; Dienemann H; Kayser K; Schulz V; Drings P; Bartsch H; Risch A
Pharmacogenetics; 2001 Mar; 11(2):157-68. PubMed ID: 11266080
[TBL] [Abstract][Full Text] [Related]
17. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians.
Gu J; Liang D; Wang Y; Lu C; Wu X
Mutat Res; 2005 Mar; 581(1-2):97-104. PubMed ID: 15725609
[TBL] [Abstract][Full Text] [Related]
18. The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction.
Taylor JA; Umbach DM; Stephens E; Castranio T; Paulson D; Robertson C; Mohler JL; Bell DA
Cancer Res; 1998 Aug; 58(16):3603-10. PubMed ID: 9721868
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women.
McGrath M; Michaud D; De Vivo I
BMC Cancer; 2006 Oct; 6():239. PubMed ID: 17026750
[TBL] [Abstract][Full Text] [Related]
20. Glutathione S-transferase (GST) M1, T1 and N-acetyltransferase 2 (NAT2) polymorphisms and urothelial cancer risk with tobacco smoking.
Tsukino H; Nakao H; Kuroda Y; Imai H; Inatomi H; Osada Y; Katoh T
Eur J Cancer Prev; 2004 Dec; 13(6):509-14. PubMed ID: 15548945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
